Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s executive management team will attend and present at GMP Securities’ 2019 Global Cannabis Conference on April 16, 2019 at The Ritz-Carlton, Toronto.
The GMP Securities’ Global Cannabis Conference will explore current investing trends, industry perspectives on consumer trends and key developments. This full day event includes company presentations, panel discussions and one-on-one meetings with senior management teams. The conference will also provide the opportunity for key industry participants and institutional investors to network and interact with a diverse group of highly regarded experts, leaders and visionaries from leading public and private cannabis companies. Details of the Company’s presentation are below:
Presenter: Dr. Patricio Stocker, Chief Executive Officer
Date: Tuesday April 16, 2019
Time: 2:10 PM
Location: Presentation Room B (The Wellington Ballroom, 4th Floor), The Ritz-Carlton, Toronto
Dr. Stocker will discuss his extensive experience in cannabis cultivation in Colombia, his vision as well as the Company’s recent operational developments including the Company’s Colombian operations, entry into Argentina, extraction facility build-out and their strategic global relationships.
“Having recently completed our public listing, we are keen to increase market awareness and this conference will provide us an excellent platform for a formal introduction to the institutional investment community,” stated Dr. Patricio Stocker, Chief Executive Officer of the Company. “As we continue to execute on our operational plans and position ourselves as leaders in Latin America, we believe there is a great opportunity for investors to participate in the growth of our company.”
About Blueberries Medical Corp.
Blueberries is a Colombia-based licensed producer of naturally grown, premium quality cannabis with operations located in the Bogotá savannah of central Colombia and is also in the process of developing a Joint Venture with an Argentinian state-owned company for the development of a medicinal cannabis in Argentina. Led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries has received all licenses required for the cultivation, production, domestic distribution, and international export of CBD (cannabidiol) and THC (tetrahydrocannabinol)-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages, and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.